Company Number: 15161056

Analysis Date: 2025-07-20 17:37 UTC

1. Credit Opinion: DECLINE
   TASHA PHARM LTD is a recently incorporated private limited company (September 2023) operating as a dispensing chemist. The latest unaudited abridged accounts to 30 September 2024 show minimal net assets (£100) and net current liabilities (£1,800). The company’s cash position (£6,685) is insufficient to cover current liabilities (£8,485), indicating weak liquidity. With only one employee (the director) and no profit reserves, the company is at a very early stage with limited financial history, which heightens credit risk. No proven track record or financial strength is evident to support loan repayment capacity. Therefore, credit approval would be declined at this stage without additional security or guarantees.

2. Financial Strength:
   The balance sheet reveals very limited fixed assets (£1,900 computer equipment) and negligible net assets (£100). The company is undercapitalized with equity matching share capital only and no retained earnings. Net current assets are negative (£-1,800), reflecting current liabilities exceeding current assets (cash only). This indicates a weak capital structure and insufficient buffer to absorb operational or financial shocks.

3. Cash Flow Assessment:
   Cash on hand of £6,685 is inadequate to meet short-term creditors of £8,485, resulting in a working capital deficit. The business depends on cash inflows not yet demonstrated in the accounts, and no profit or loss account data is available to assess operational cash generation. Liquidity risk is elevated, and the company’s ability to service debt or meet payment obligations promptly is uncertain.

4. Monitoring Points:

• Improvement in liquidity position and working capital management
• Generation of positive operating cash flows and profit reserves
• Timely payments to creditors and absence of overdue liabilities
• Development of a credible trading history and turnover growth
• Stability and conduct of the sole director who is also the controlling shareholder